The psychoneuroimmunology of postpartum depression

Journal of Women's Health

Volumn 17, Issue 9, 2008, Pages 1529-1534

  Corwin, Elizabeth J ^a   Pajer, Kathleen ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCEPTUAL FRAMEWORK; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNE DYSREGULATION; INFLAMMATION; INNATE IMMUNITY; MATERNAL WELFARE; PREGNANCY; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; PUERPERAL DEPRESSION; PUERPERIUM; REVIEW;

CYTOKINES; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNE SYSTEM; PITUITARY-ADRENAL SYSTEM; PREGNANCY; PSYCHONEUROIMMUNOLOGY;

EID: 56249094842     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2007.0725     Document Type: Review

References (62)

1. Cooper PJ, Murray L. Postnatal depression. BMJ 1998;316:1884.
2. Boath E, Bradley E, Henshaw C. The prevention of postnatal depression: A narrative systematic review. J Psychosom Obstet Gynaecol 2005;26:185.
3. McCoy SJ, Beal JM, Watson GH. Endocrine factors and postpartum depression. A selected review. J Reprod Med 2003;48:402.
4. Wisner KL, Stowe ZN. Psychobiology of postpartum mood disorders. Semin Reprod Endocrinol 1997;15:77.
5. Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T. Perinatal depression A systematic review of prevalence and incidence. Obstet Gynecol 2005;106:1071.
6. Wisner KL, Chambers C, Sit DK. Postpartum depression: A major public health problem. JAMA 2006;296:2616.
7. Munk-Olsen T, Laursen TM, Pedersen CB, Mors O, Mortensen PB. New parents and mental disorders: A population-based register study. JAMA 2006;296:2582.
8. Martins C, Gaffan EA. Effects of early maternal depression on patterns of infant-mother attachment: A meta-analytic investigation. J Child Psychol Psychiatry 2000;41:737.
9. Beck CT. The effects of postpartum depression on maternal-infant interaction: A meta-analysis. Nurs Res 1995;44:298.
10. Beck CT. The effects of postpartum depression on child development: A meta-analysis. Arch Psychiatr Nurs 1998;12:12.
11. Field T. Infants of depressed mothers. Infant Behav Dev 1995;18:1.
12. Hay DF, Pawlby S, Angold A, Harold GT, Sharp D. Pathways to violence in the children of mothers who were depressed postpartum. Dev Psychol 2003;39:1083.
13. Logsdon MC, Wisner KL, Pinto-Foltz MD. The impact of postpartum depression on mothering. J Obstet Gynecol Neonatal Nurs 2006;35:652.
14. Wisner KL, Perel JM, Peindl KS, Hanusa BH, Piontek CM, Findling RL. Prevention of postpartum depression: A pilot randomized clinical trial. Am J Psychiatry 2004;161:1290.
15. Bloch M, Rotenberg N, Koren D, Klein E. Risk factors for early postpartum depressive symptoms. Gen Hosp Psychiatry 2006;28:3.
16. Rich-Edwards JW, Kleinman K, Abrams A, et al. Sociodemographic predictors of antenatal and postpartum depressive symptoms among women in a medical group practice. J Epidemiol Community Health 2006;60:221.
17. Pedersen CA, Stern RA, Pate J, Senger MA, Bowes WA, Mason GA. Thyroid and adrenal measures during later pregnancy and the puerperium in women who have been depressed or who become dysphoric postpartum. J Affect Disord 1993;29:201.
18. Bloch M, Daly RC, Rubinow DR. Endocrine factors in the etiology of postpartum depression. Compr Psychiatry 2003;44:234.
19. Lucas A, Pizarro E, Granada ML, Salinas I, Fox M, Sanmarti A. Postpartum thyroiditis: Epidemiology and clinical evolution in a non-selected population. Thyroid 2000;10:71.
20. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000;157:924.
21. Watkins LR, Nguyen KT, Lee JE, Maier SF. Dynamic regulation of proinflammatory cytokines. Adv Exp Med Biol 1999;461:153.
22. Anisman H, Merali Z. Cytokines, stress and depressive illness: Brain-immune interactions. Ann Med 2003;35:2.
23. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683.
24. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000;117:1162-1172.
25. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24.
26. Constant A, Castera L, Dantzer R, et al. Mood alterations during interferon-alpha therapy in patients with chronic hepatitis C: Evidence for an overlap between manic/hypomanic and depressive symptoms. J Clin Psychiatry 2005;66:1050.
27. Wichers MC, Kenis G, Koek GH, Robaeys G, Nicolson NA, Maes M. Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol. J Psychosom Res 2007;62:207.
28. Dentino AN, Pieper CF, Rao MK, et al. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc 1999;47:6.
29. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:201.
30. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002;53:865.
31. Charmandari E, Tsigos C, Chrousos G. Endocrinology of the stress response. Annu Rev Physiol 2005;67:259.
32. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351.
33. Kiecolt-Glaser JK, Glaser R. Depression and immune function: Central pathways to morbidity and mortality. J Psychosomat Res 2002;53:873.
34. Nemeroff CB. The neurobiology of depression. Sci Am 1998;278:42.
35. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. JAMA 1992;267:1244.
36. Shea A, Walsh C, Macmillan H, Steiner M. Child maltreatment and HPA axis dysregulation: Relationship to major depressive disorder and posttraumatic stress disorder in females. Biol Psychiatry 2005;30:162.
37. Chrousos GP, Kino T. Interactive functional specificity of the stress and immune responses: The ying, the yang, and the defense against 2 major classes of bacteria. J Infect Dis 2005;192:551.
38. McCann SM, Kimura M, Karanth S, Yu WH, Mastronardi CA, Rettori V. The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection. Ann NY Acad Sci 2000;917:4.
39. Pace TW, Hu F, Miller AH. Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 2007;21:9.
40. Elenkov IJ, Chrousos GP. Stress hormones, proinflammatory and anti-inflammatory cytokines, and autoimmunity. Ann NY Acad Sci 2002;966:290.
41. Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 2005;12:255.
42. Østensen M, Förger F, Nelson JL, Schuhmacher A, Hebisch G, Villiger PM. Pregnancy in patients with rheumatic disease: Anti-inflammatory cytokines increase in pregnancy and decrease postpartum. Ann Rhuem Dis 2005;64:839.
43. Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T. Interleukin-12 secretion by peripheral blood mononuclear cells is decreased in normal pregnant subjects and increased in preeclamptic patients. Clin Exp Immunol 1999;117:550.
44. Veenstra van Nieuwenhoven AL, Bouman A, Moes H, et al. Endotoxin-induced cytokine production of monocytes of third-trimester pregnant women compared with women in the follicular phase of the menstrual cycle. Obstet Gynecol 2003;188:1073.
45. Salamonsen LA. Tissue injury and repair in the female human reproductive tract. Reproduction 2003;125:301.
46. Kayisli UA, Mahutte NG, Arici A. Uterine chemokines in reproductive physiology and pathology. Am J Reprod Immunol 2002;47:213.
47. Hebisch G, Neumaier-Wagner PM, Huch R. Maternal serum interleukin-1b, -6 and -8 levels and potential determinants in pregnancy and peripartum. J Perinat Med 2004;32:475.
48. Vassiliadis S, Ranella A, Papadimitriou L, Makrygiannakis A, Athanassakis I. Serum levels of pro- and anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion. Mediators Inflamm 1998;7:69.
49. Corwin EJ, Bozoky I, Pugh LC, Johnston N. Interleukin-1beta elevation during the postpartum period. Ann Behav Med 2003;25:41.
50. Shimaoka Y, Hidaka Y, Tada H, et al. Changes in cytokine production during and after normal pregnancy. Am J Reprod Immunol 2000;44:143.
51. Keski-Nisula L, Hirvonen MR, Roponen M, Heinonen S, Pekkanen J. Maternal and neonatal IL-4 and IFN-gamma production at delivery and 3 months after birth. J Reprod Immunol 2003;60:25.
52. Mastorakos G, Ilias I. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann NY Acad Sci 2003;997:136.
53. Makrigiannakis A, Zoumakis E, Kalantaridou S, Chrousos G. Endometrial and placental CRH as regulators of human embryo implantation. J Reprod Immunol 2004;62:53.
54. Maes M, Lin AH, Ombelet W, et al. Immune activation in the early puerperium is related to postpartum anxiety and depressive symptoms. Psychoneuroendocrinology 2000;25:121.
55. Maes M, Ombelet W, De Jongh R, Kenis G, Bosmans E. The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system. J Affect Disord 2001;63:85.
56. Schmeelk KH, Granger DA, Susman EJ, Chrousos GP. Maternal depression and risk for postpartum complications: Role of prenatal corticotropin-releasing hormone and interleukin-1 receptor antagonist. Behav Med 1999;25:88.
57. Groer MW, Morgan K. Immune, health and endocrine characteristics of depressed postpartum mothers. Psychoneuroendocrinology 2007;32:133.
58. Gennaro S, Dunphy P, Dowd M, Fehder W, Douglas SD. Postpartum smoking behaviors and immune response in mothers of term and preterm infants. Res Nurs Health 2001;24:9.
59. McCoy SJ, Beal JM, Shipman SB, Payton ME, Watson GH. Risk factors for postpartum depression: A retrospective investigation at 4 weeks postnatal and a review of the literature. J Am Osteopath Assoc 2006;106:193.
60. Harris B, Lovett L, Smith J, Read G, Walker R, Newcombe R. Cardiff puerperal mood and hormone study. III. Postnatal depression at 5 to 6 weeks postpartum, and its hormonal correlates across the peripartum period. Br J Psychiatry 1996;168:739.
61. Magiakou MA, Mastorakos G, Rabin D, Dubbert B, Gold PW, Chrousos GP. Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: Implications for the increase in psychiatric manifestations at this time. J Clin Endocrinol Metab 1996;81:1912.
62. Parry BL, Sorenson DL, Meliska CJ, et al. Hormonal basis of mood and postpartum disorders. Curr Womens Health Rep 2003;3:230.